MARSHALL WACE, LLP

Position in STIM — Neuronetics, Inc.

CIK 1318757 LONDON, X0

Position in STIM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$631,399

+$236,658 QoQ

Shares Held

485,692

+69.8% QoQ

Ownership

0.637%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 86 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. STIM ranks #45 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	5,542,438	$502,920,823
2	BSX	Boston Scientific Corp	2,414,223	$103,039,037
3	GKOS	GLAUKOS Corp	314,804	$43,997,006
4	DXCM	Dexcom Inc	532,804	$35,884,349
5	EW	Edwards Lifesciences Corp	344,361	$31,150,895
6	PEN	Penumbra Inc	90,520	$28,581,689
7	SYK	Stryker Corp	51,116	$16,093,361
8	GMED	Globus Medical Inc	188,541	$14,896,623

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$631,399	485,692	+69.8%	Shares	Other	2026-08-13
2025-12-31	$394,741	286,045	-69.1%	Shares	Other	2026-02-13
2025-09-30	$2,525,550	925,110	+2039.3%	Shares	Other	2025-11-13
2025-06-30	$150,918	43,243	-20.7%	Shares	Other	2025-08-13
2025-03-31	$200,626	54,518	+416.7%	Shares	Other	2025-05-15
2024-06-30	$18,993	10,552	-95.2%	Shares	Other	2024-08-14
2024-03-31	$1,035,961	217,639	+51.8%	Shares	Other	2024-05-15
2023-12-31	$415,651	143,328	+182.3%	Shares	Other	2024-02-14
2023-03-31	$147,746	50,772	+141.3%	Shares	Other	2023-05-15
2022-12-31	$144,524	21,037	-76.9%	Shares	Other	2023-02-14
2021-03-31	$1,124,581	90,912	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.